BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
Musculoskeletal RSS Feed RSS

Topline phase II data with Sarconeos in sarcopenia

Aug. 2, 2021

New glucocorticoid receptor modulators identified at Medshine Discovery

Aug. 2, 2021

Nuclear receptor ROR-gamma modulators discovered at Nuevolution

July 16, 2021

Enrollment opens in first-in-human study of VIB-1116 for rheumatic diseases

July 15, 2021

Carna reports phase I SAD data on BTK inhibitor AS-0871

July 13, 2021

Landos Biopharma patents new LANCL2 activators

July 9, 2021

SHR-1314 studied in phase II/III trial for active ankylosing spondylitis

July 5, 2021

LG Chem reports data from phase II CLUE study of LC-350189 in chronic gout

July 2, 2021

Histogen opens phase I/II study of HST-003 for regeneration of knee cartilage

July 1, 2021

LG Chem patents sphingosine 1-phosphate receptor 1 agonists

July 1, 2021
Previous 1 2 … 60 61 62 63 64 65 66 67 68 … 605 606 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 28, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Cerebral aneurysm illustration

    Grace Therapeutics hits CRL setback with GTx-104 despite positive trial

    BioWorld
    Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
  • Epileptic brain and abnormal EEG wave discharges

    Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest

    BioWorld
    A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
  • Gold-encircled handshake

    Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal

    BioWorld
    The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing